Search hospitals
>
Kansas
>
Wellington
Cancer Center of Kansas - Wellington
Claim this profile
Wellington, Kansas 67152
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Lymphoma
Conducts research for Ovarian Cancer
396 reported clinical trials
2 medical researchers
Summary
Cancer Center of Kansas - Wellington is a medical facility located in Wellington, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Ovarian Cancer and other specialties. Cancer Center of Kansas - Wellington is involved with conducting 396 clinical trials across 417 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.
Area of expertise
Breast Cancer
Cancer Center of Kansas - Wellington has run 82 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Cancer Center of Kansas - Wellington has run 56 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Shaker Dakhil, M.D.
Ascension Via Christi Hospitals Wichita
7 years of reported clinical research
Dennis F. Moore
Ascension Via Christi Hospitals Wichita
5 years of reported clinical research
Clinical Trials running at Cancer Center of Kansas - Wellington
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Breast Cancer
Breast cancer
Kidney Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Cancer
Prostate Cancer
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cancer Center of Kansas - Wellington?
Cancer Center of Kansas - Wellington is a medical facility located in Wellington, Kansas. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Lymphoma, Ovarian Cancer and other specialties. Cancer Center of Kansas - Wellington is involved with conducting 396 clinical trials across 417 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.
Where is Cancer Center of Kansas - Wellington located?
The Cancer Center of Kansas in Wellington is located at 507 E 16th St, Wellington, KS 67152.
Who should I call to ask about financial aid or insurance network?
**Cancer Center of Kansas - Wellington Financial Assistance Information:** - For financial and insurance inquiries, contact the Patient Financial Service Department at (866) 772-6309 or (561) 798-8678, Monday to Friday, 8:30 a.m. - 4:30 p.m. - Patient Assistance Counselors are available to help eligible patients secure financial assistance for cancer treatment costs. They collaborate with drug manufacturers, foundations, and local oncology societies to provide copay assistance or grants. - Eligibility for assistance varies, often requiring proof of income and signed forms. Additional resources are available through Ascension Medical Group Via Christi in Wellington for cancer patients.
What insurance does Cancer Center of Kansas - Wellington accept?
The Cancer Center of Kansas (CCK) accepts Medicare, most major insurance carriers, Medicaid for Kansas, Missouri, and Oklahoma, and provides services to uninsured individuals. Ensure you have a referral from your primary care physician if your insurance requires one before your appointment. The CCK Business Office handles billing, coordinates payments, communicates with insurance companies for proper payment, obtains prior authorizations and necessary referrals, facilitates patient assistance, and ensures patients receive maximum benefits from their insurance plans.
What awards or recognition has Cancer Center of Kansas - Wellington received?
The Cancer Center of Kansas - Wellington has been awarded the Kansas Health Information Networks Certificate of Achievement and named the Wichita Kansas Reader's Choice Favorite Cancer Center in 2016 and 2018. It has been recognized as a 2016 Admirable Statewide Partner for its outstanding dedication. The center participates in clinical trials recognized by leading institutions, including the National Cancer Institute, Southwest Oncology Group, and Memorial Sloan Kettering Cancer Center.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.